Canlyniadau Chwilio - Judith Anzures‐Cabrera

  • Dangos 1 - 7 canlyniadau o 7
Mireinio'r Canlyniadau
  1. 1
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids

    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids gan Philip Korenblat, Edwin Kerwin, И. В. Лещенко, Karl Yen, Cécile Holweg, Judith Anzures‐Cabrera, Carmen Martín, Wendy S. Putnam, Laura Governale, Julie Olsson, John G. Matthews

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)

    Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS) gan Stanley J. Szefler, Graham Roberts, Adalberto Sperb Rubin, Stefan Zielen, Piotr Kuna, Oral Alpan, Judith Anzures‐Cabrera, Qiang Chen, Cécile Holweg, Janusz Kamiński, Wendy S. Putnam, John G. Matthews, Nikhil Kamath

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial

    The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial gan Kausik K. Ray, Marc Ditmarsch, David Kallend, Eric J. Niesor, Gabriela Suchánková, Ruchi Upmanyu, Judith Anzures‐Cabrera, Valerie Lehnert, Meike Pauly-Evers, Ingar Holme, Josef Šťásek, M. W. J. van Hessen, Peter J.H. Jones

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease

    Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease gan Gennaro Pagano, Kirsten I. Taylor, Judith Anzures Cabrera, Tanya Simuni, Kenneth Marek, Ronald B. Postuma, Nicola Pavese, Fabrizio Stocchi, Kathrin Brockmann, Hanno Svoboda, Dylan Trundell, Annabelle Monnet, Rachelle S. Doody, Paulo Fontoura, Geoffrey A. Kerchner, Patrik Brundin, Tania Nikolcheva, Azad Bonni

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

    A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data gan Gennaro Pagano, Frank Boess, Kirsten I. Taylor, Benedicte Ricci, Brit Mollenhauer, Werner Poewe, Anne Boulay, Judith Anzures‐Cabrera, Annamarie Vogt, Maddalena Marchesi, Anke Post, Tania Nikolcheva, Gene G. Kinney, Wagner Zago, Daniel Ness, Hanno Svoboda, Markus Britschgi, Susanne Ostrowitzki, Tanya Simuni, Kenneth Marek, Martin Koller, Jeff Sevigny, Rachelle S. Doody, Paulo Fontoura, Daniel Umbricht, Azad Bonni

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

    The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria gan Alexander Röth, J Nishimura, Zsolt Nagy, Júlia Gaál-Weisinger, Jens Panse, Sung‐Soo Yoon, Miklós Egyed, Satoshi Ichikawa, Yoshikazu Ito, Jin Seok Kim, Haruhiko Ninomiya, Hubert Schrezenmeier, Simona Sica, Kensuke Usuki, Flore Sicre de Fontbrune, Juliette Soret, Alexandre Sostelly, James Higginson, Andreas Dieckmann, Brittany Gentile, Judith Anzures‐Cabrera, Kenji Shinomiya, Gregor Jordan, Marta Biedzka-Sarek, Barbara Klughammer, Angelika Jahreis, Christoph Bucher, Régis Peffault de Latour

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Trial of Prasinezumab in Early-Stage Parkinson’s Disease

    Trial of Prasinezumab in Early-Stage Parkinson’s Disease gan Gennaro Pagano, Kirsten I. Taylor, Judith Anzures‐Cabrera, Maddalena Marchesi, Tanya Simuni, Kenneth Marek, Ronald B. Postuma, Nicola Pavese, Fabrizio Stocchi, Jean‐Philippe Azulay, Brit Mollenhauer, Lydia López Manzanares, David Russell, James T. Boyd, Anthony P. Nicholas, M.R. Luquin, Robert A. Hauser, Thomas Gasser, Werner Poewe, Benedicte Ricci, Anne Boulay, Annamarie Vogt, Frank Boess, Juergen Dukart, Giulia D’Urso, Rebecca Finch, Stefano Zanigni, Annabelle Monnet, Nathalie Pross, Andrea Hahn, Hanno Svoboda, Markus Britschgi, Florian Lipsmeier, Ekaterina Volkova-Volkmar, Michael Lindemann, Sebastian Dziadek, Štefan Holiga, Daria Rukina, Thomas Kustermann, Geoffrey A. Kerchner, Paulo Fontoura, Daniel Umbricht, Rachelle S. Doody, Tania Nikolcheva, Azad Bonni

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: